Literature DB >> 31812840

Evaluation of sagittal airway dimensions after face mask therapy with rapid maxillary expansion in Class III growing patients.

Elisabetta Cretella Lombardo1, Lorenzo Franchi2, Roberta Lione3, Alice Chiavaroli3, Paola Cozza4, Chiara Pavoni3.   

Abstract

OBJECTIVE: The aim of this investigation was to analyze the effects of RME and FM on the airway dimensions in Class III patients compared with untreated controls.
METHODS: A sample of 47 Class III patients treated with RME and FM was analyzed. The treated group was compared with 18 untreated controls. Lateral cephalograms for each patient at T1, T2, and T3 were digitized.
RESULTS: At long-term evaluation a significant increase in airway size and a significant decrease in adenoid size were found in the treated group as well as an improvement in the pharynx dimension. During active treatment the treated group showed a significant improvement in lower airway size and in lower pharynx dimension. A significant decrease in adenoid size was also found.
CONCLUSION: The treatment with RME and FM produced favorable stable changes in the airway dimensions in Class III subjects when compared with untreated controls.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Airway; Class III malocclusion; Growing patients

Year:  2019        PMID: 31812840     DOI: 10.1016/j.ijporl.2019.109794

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  2 in total

1.  Relationship between craniofacial and dental arch morphology with pharyngeal airway space in adolescents.

Authors:  Izabel de Oliveira; Raysa Pinheiro; Benedito Freitas; Peter Reher; Vandilson Rodrigues
Journal:  J Orofac Orthop       Date:  2022-05-24       Impact factor: 1.938

2.  The Airway Volume Related to the Maxillo-Mandibular Position Using 3D Analysis.

Authors:  Víctor Ravelo; Gabriela Olate; Gonzalo Muñoz; Márcio de Moraes; Sergio Olate
Journal:  Biomed Res Int       Date:  2021-06-21       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.